Cel Sci Corporation (CVM)

[GD]

It seems Geert wants to follow AMRN's foot steps of
in bed with street to kill all the Jan calls above 15
by releasing the data on Jan 18. In Sept 2018,
AMRN had 22+m shares in Sept calls expired on Sept
21 and AMRN held the data to PR on Sept 24, Monday
morning, some how what goes around comes around to
AMRN back to 5 again now. One thing is proved to be true
that AMRN CEO insisted that interim looks did not stop
the trial was because AMRN wanted the secondary endpoint
of mortality rate to mature and show SS efficacy,
and this may be happen with CVM too that Geert keep
saying 298 events for true MK OS efficacy. Any way,
the data should be ready by now, using Geert's own words
in today's letter:

"experts are now analyzing the data according to a statistical analysis
plan that was agreed to and finalized before database lock."

VERY IMPORTANT: " a statistical analysis plan that was agreed to and finalized before database lock"

after data base is locked, CRO should unbline it, run software through it
and print out the results, without the primary OS endpoint being
SS, the trial fails, period!